rs1041981

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000595.4(LTA):​c.179C>A​(p.Thr60Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 1,611,200 control chromosomes in the GnomAD database, including 103,451 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign,risk factor (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T60A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.38 ( 11465 hom., cov: 28)
Exomes 𝑓: 0.35 ( 91986 hom. )

Consequence

LTA
NM_000595.4 missense

Scores

2
15

Clinical Significance

Benign; risk factor no assertion criteria provided B:1O:1

Conservation

PhyloP100: 0.741

Publications

257 publications found
Variant links:
Genes affected
LTA (HGNC:6709): (lymphotoxin alpha) The encoded protein, a member of the tumor necrosis factor family, is a cytokine produced by lymphocytes. The protein is highly inducible, secreted, and forms heterotrimers with lymphotoxin-beta which anchor lymphotoxin-alpha to the cell surface. This protein also mediates a large variety of inflammatory, immunostimulatory, and antiviral responses, is involved in the formation of secondary lymphoid organs during development and plays a role in apoptosis. Genetic variations in this gene are associated with susceptibility to leprosy type 4, myocardial infarction, non-Hodgkin's lymphoma, and psoriatic arthritis. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jul 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.4083595E-4).
BP6
Variant 6-31573007-C-A is Benign according to our data. Variant chr6-31573007-C-A is described in ClinVar as Benign|risk_factor. ClinVar VariationId is 14379.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.496 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LTANM_000595.4 linkc.179C>A p.Thr60Asn missense_variant Exon 3 of 4 ENST00000418386.3 NP_000586.2 P01374Q5STV3
LTANM_001159740.2 linkc.179C>A p.Thr60Asn missense_variant Exon 3 of 4 NP_001153212.1 P01374Q5STV3
LTAXM_047418773.1 linkc.179C>A p.Thr60Asn missense_variant Exon 5 of 6 XP_047274729.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LTAENST00000418386.3 linkc.179C>A p.Thr60Asn missense_variant Exon 3 of 4 1 NM_000595.4 ENSP00000413450.2 P01374

Frequencies

GnomAD3 genomes
AF:
0.381
AC:
57634
AN:
151122
Hom.:
11454
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.502
Gnomad AMI
AF:
0.366
Gnomad AMR
AF:
0.346
Gnomad ASJ
AF:
0.241
Gnomad EAS
AF:
0.471
Gnomad SAS
AF:
0.277
Gnomad FIN
AF:
0.298
Gnomad MID
AF:
0.341
Gnomad NFE
AF:
0.339
Gnomad OTH
AF:
0.350
GnomAD2 exomes
AF:
0.347
AC:
85595
AN:
246840
AF XY:
0.339
show subpopulations
Gnomad AFR exome
AF:
0.501
Gnomad AMR exome
AF:
0.338
Gnomad ASJ exome
AF:
0.241
Gnomad EAS exome
AF:
0.498
Gnomad FIN exome
AF:
0.300
Gnomad NFE exome
AF:
0.338
Gnomad OTH exome
AF:
0.331
GnomAD4 exome
AF:
0.351
AC:
512722
AN:
1459960
Hom.:
91986
Cov.:
44
AF XY:
0.348
AC XY:
252459
AN XY:
726340
show subpopulations
African (AFR)
AF:
0.508
AC:
17003
AN:
33460
American (AMR)
AF:
0.336
AC:
14993
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
6524
AN:
26128
East Asian (EAS)
AF:
0.434
AC:
17213
AN:
39694
South Asian (SAS)
AF:
0.284
AC:
24521
AN:
86238
European-Finnish (FIN)
AF:
0.313
AC:
16388
AN:
52316
Middle Eastern (MID)
AF:
0.346
AC:
1998
AN:
5768
European-Non Finnish (NFE)
AF:
0.353
AC:
392842
AN:
1111304
Other (OTH)
AF:
0.352
AC:
21240
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
17885
35771
53656
71542
89427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12788
25576
38364
51152
63940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.381
AC:
57687
AN:
151240
Hom.:
11465
Cov.:
28
AF XY:
0.377
AC XY:
27836
AN XY:
73858
show subpopulations
African (AFR)
AF:
0.502
AC:
20649
AN:
41150
American (AMR)
AF:
0.346
AC:
5258
AN:
15204
Ashkenazi Jewish (ASJ)
AF:
0.241
AC:
837
AN:
3468
East Asian (EAS)
AF:
0.471
AC:
2382
AN:
5060
South Asian (SAS)
AF:
0.277
AC:
1331
AN:
4806
European-Finnish (FIN)
AF:
0.298
AC:
3125
AN:
10476
Middle Eastern (MID)
AF:
0.318
AC:
93
AN:
292
European-Non Finnish (NFE)
AF:
0.339
AC:
22953
AN:
67788
Other (OTH)
AF:
0.348
AC:
727
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1663
3325
4988
6650
8313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.351
Hom.:
45322
Bravo
AF:
0.391
TwinsUK
AF:
0.375
AC:
1391
ALSPAC
AF:
0.379
AC:
1459
ESP6500AA
AF:
0.511
AC:
1543
ESP6500EA
AF:
0.331
AC:
1793
ExAC
AF:
0.347
AC:
41204
Asia WGS
AF:
0.329
AC:
1145
AN:
3478
EpiCase
AF:
0.318
EpiControl
AF:
0.322

ClinVar

Significance: Benign; risk factor
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

LTA-related disorder Benign:1
Oct 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Myocardial infarction, susceptibility to Other:1
Sep 01, 2004
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
15
DANN
Benign
0.95
DEOGEN2
Benign
0.17
T;T
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.26
FATHMM_MKL
Benign
0.42
N
MetaRNN
Benign
0.00044
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.0
M;M
PhyloP100
0.74
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.010
N;N
REVEL
Benign
0.025
Sift
Benign
0.39
T;T
Sift4G
Uncertain
0.045
D;D
Polyphen
0.0050
B;B
Vest4
0.047
MPC
1.1
ClinPred
0.0010
T
GERP RS
3.1
Varity_R
0.030
gMVP
0.30
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1041981; hg19: chr6-31540784; COSMIC: COSV69304640; COSMIC: COSV69304640; API